Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial

DOI: 10.1016/j.ygyno.2020.01.005

Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance

DOI: 10.1016/j.ccell.2020.03.012

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study

DOI: 10.1186/s12885-021-08097-9

MANIFEST: Multiomic Platform for Cancer Immunotherapy

DOI: 10.1158/2159-8290.CD-25-0099

Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis

DOI: 10.1158/2159-8290.CD-24-1224 Abstract

Small-cell lung cancer: anatomy of an immune-cold tumor

DOI: 10.1016/j.trecan.2025.11.011

Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial

DOI: 10.1016/j.iotech.2024.100712